Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Herpes zoster
Human papillomavirus (HPV)
Mpox // Monkeypox
Rabies
2022
2021
Western Pacific
Clear all
Type of publications
NITAG documentation
(2)
Systematic reviews (SYSVAC)
(6)
Topics
Available to download in languages
Regions
Western Pacific
(8)
Africa
(3)
Americas
(19)
Europe
(17)
South-East Asia
(3)
Countries
Australia
(2)
China
(4)
Diseases
Herpes zoster
(1)
Human papillomavirus (HPV)
(5)
Mpox // Monkeypox
(1)
Rabies
(1)
COVID-19
(31)
Hepatitis B
(1)
Influenza
(4)
Japanese encephalitis
(1)
Pertussis
(2)
Pneumococcal disease
(4)
Varicella
(1)
Vaccine topics
Acceptance
(2)
Coverage
(1)
Economic aspects
(2)
Efficacy/effectiveness
(1)
Safety
(1)
Target population
Adolescents
(4)
Adults
(3)
All age groups
(2)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Publication date
2022
(5)
2021
(3)
2023
(2)
2020
(1)
2019
(1)
2018
(2)
2017
(3)
2016
(1)
2015
(3)
2013
(2)
2011
(1)
2010
(3)
2008
(1)
8 results found
2022
∙
Wang, D. Wu, J. Du, J. Ong, H. Tang, B. Dozier, M. Weller, D. Campbell, C.
Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature
2022
∙
Ren, X. Hao, Y. Wu, B. Jia, X. Niu, M. Wang, K. Li, Z.
Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis
2022
∙
Bai, Y. Ip, P. Chan, K. Ngan, H. Yip, P.
HPV Vaccination Intentions of Female Students in Chinese Universities: A Systematic Literature Review and Meta-Analysis
2022
∙
Zhu, K. Tian, Y. Dong, X. Akinwunmi, B. O. Zhang, C. J. P. Huang, J. Ming, W. K.
The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
2022
∙
ATAGI
ATAGI clinical guidance on vaccination against Monkeypox
2021
∙
Shi, W. Cheng, X. Wang, H. Zang, X. Chen, T.
Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies
2021
∙
Li, W. Liu, S. Qian, S. Zhu, J. Selvaraj, J. N. Zhang, X.
Is the rate of adverse reaction to rabies vaccine in China really as the public thinks?—based on a meta analysis
2021
∙
ATAGI
Statement on the Clinical use of Zoster vaccine in older adults in Australia - 8 July 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register